Your browser doesn't support javascript.
loading
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells.
Kumar, Harish; Mazumder, Suman; Sharma, Neeraj; Chakravarti, Sayak; Long, Mark D; Meurice, Nathalie; Petit, Joachim; Liu, Song; Chesi, Marta; Sanyal, Sabyasachi; Stewart, A Keith; Kumar, Shaji; Bergsagel, Leif; Rajkumar, S Vincent; Baughn, Linda B; Van Ness, Brian G; Mitra, Amit Kumar.
Afiliación
  • Kumar H; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
  • Mazumder S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
  • Sharma N; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
  • Chakravarti S; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Long MD; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, United States.
  • Meurice N; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Petit J; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
  • Liu S; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
  • Chesi M; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
  • Sanyal S; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
  • Stewart AK; Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • Kumar S; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
  • Bergsagel L; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
  • Rajkumar SV; Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
  • Baughn LB; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
  • Van Ness BG; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
  • Mitra AK; Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, United States.
Front Oncol ; 12: 842200, 2022.
Article en En | MEDLINE | ID: mdl-35646666

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos